The non-canonical functions of p27^Kip1 in normal and tumor biology

References

• Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 1993; 260:536-9; PMID:8475385; http://dx.doi.org/10.1126/science.8475385
   PubMed Web of Science ®Google Scholar
• Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci U S A 1994; 91:5291-5; PMID:8202483; http://dx.doi.org/10.1073/pnas.91.12.5291
   PubMed Web of Science ®Google Scholar
• Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994; 8:9-22; PMID:8288131; http://dx.doi.org/10.1101/gad.8.1.9
   PubMed Web of Science ®Google Scholar
• Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-66; PMID:8033212; http://dx.doi.org/10.1016/0092-8674(94)90572-X
   PubMed Web of Science ®Google Scholar
• Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MR, Reed SI. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol 1994; 14:3683-94; PMID:8196612; http://dx.doi.org/10.1128/MCB.14.6.3683
   PubMed Web of Science ®Google Scholar
• Bagui TK, Jackson RJ, Agrawal D, Pledger WJ. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1). Mol Cell Biol 2000; 20:8748-57; PMID:11073976; http://dx.doi.org/10.1128/MCB.20.23.8748-8757.2000
   PubMed Web of Science ®Google Scholar
• Dong F, Agrawal D, Bagui T, Pledger WJ. Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells. Mol Biol Cell 1998; 9:2081-92; PMID:9693368; http://dx.doi.org/10.1091/mbc.9.8.2081
   PubMed Web of Science ®Google Scholar
• Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78:67-74; PMID:8033213; http://dx.doi.org/10.1016/0092-8674(94)90573-8
   PubMed Web of Science ®Google Scholar
• Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 1996; 382:325-31; PMID:8684460; http://dx.doi.org/10.1038/382325a0
   PubMed Web of Science ®Google Scholar
• Agrawal D, Hauser P, McPherson F, Dong F, Garcia A, Pledger WJ. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 1996; 16:4327-36; PMID:8754833; http://dx.doi.org/10.1128/MCB.16.8.4327
   PubMed Web of Science ®Google Scholar
• Zhang X, Wharton W, Donovan M, Coppola D, Croxton R, Cress WD, Pledger WJ. Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1). Mol Biol Cell 2000; 11:2117-30; PMID:10848633; http://dx.doi.org/10.1091/mbc.11.6.2117
   PubMed Web of Science ®Google Scholar
• Bagui TK, Cui D, Roy S, Mohapatra S, Shor AC, Ma L, Pledger WJ. Inhibition of p27Kip1 gene transcription by mitogens. Cell Cycle 2009; 8:115-24; PMID:19158484; http://dx.doi.org/10.4161/cc.8.1.7527
   PubMed Web of Science ®Google Scholar
• Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1:193-9; PMID:10559916; http://dx.doi.org/10.1038/12013
   PubMed Web of Science ®Google Scholar
• Hara T, Kamura T, Nakayama K, Oshikawa K, Hatakeyama S. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J Biol Chem 2001; 276:48937-43; PMID:11682478; http://dx.doi.org/10.1074/jbc.M107274200
   PubMed Web of Science ®Google Scholar
• Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakides TR, Roberts JM. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 2001; 413:323-7; PMID:11565035; http://dx.doi.org/10.1038/35095083
   PubMed Web of Science ®Google Scholar
• Kamura T, Hara T, Matsumoto M, Ishida N, Okumura F, Hatakeyama S, Yoshida M, Nakayama K, Nakayama KI. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol 2004; 6:1229-35; PMID:15531880; http://dx.doi.org/10.1038/ncb1194
   PubMed Web of Science ®Google Scholar
• Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996; 85:733-44; PMID:8646781; http://dx.doi.org/10.1016/S0092-8674(00)81239-8
   PubMed Web of Science ®Google Scholar
• Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 1996; 85:721-32; PMID:8646780; http://dx.doi.org/10.1016/S0092-8674(00)81238-6
   PubMed Web of Science ®Google Scholar
• Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996; 85:707-20; PMID:8646779; http://dx.doi.org/10.1016/S0092-8674(00)81237-4
   PubMed Web of Science ®Google Scholar
• Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 1998; 396:177-80; PMID:9823898; http://dx.doi.org/10.1038/24179
   PubMed Web of Science ®Google Scholar
• Jackson RJ, Adnane J, Coppola D, Cantor A, Sebti SM, Pledger WJ. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models. Oncogene 2002; 21:8486-97; PMID:12466968; http://dx.doi.org/10.1038/sj.onc.1205946
   PubMed Web of Science ®Google Scholar
• Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev 2006; 20:47-64; PMID:16391232; http://dx.doi.org/10.1101/gad.1384406
   PubMed Web of Science ®Google Scholar
• Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 2000; 20:6147-58; PMID:10913196; http://dx.doi.org/10.1128/MCB.20.16.6147-6158.2000
   PubMed Web of Science ®Google Scholar
• Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 2001; 27:222-4; PMID:11175795; http://dx.doi.org/10.1038/84879
   PubMed Web of Science ®Google Scholar
• Park MS, Rosai J, Nguyen HT, Capodieci P, Cordon-Cardo C, Koff A. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc Natl Acad Sci U S A 1999; 96:6382-7; PMID:10339596; http://dx.doi.org/10.1073/pnas.96.11.6382
   PubMed Web of Science ®Google Scholar
• Martin-Caballero J, Flores JM, Garcia-Palencia P, Collado M, Serrano M. Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice. Oncogene 2004; 23:8231-7; PMID:15378017; http://dx.doi.org/10.1038/sj.onc.1207863
   PubMed Web of Science ®Google Scholar
• Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J, Atkinson MJ. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A 2006; 103:15558-63; PMID:17030811; http://dx.doi.org/10.1073/pnas.0603877103
   PubMed Web of Science ®Google Scholar
• Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Makinen MJ, Tuppurainen K, Paschke R, et al. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J clin endocrinol Metab 2007; 92:3321-5; PMID:17519308; http://dx.doi.org/10.1210/jc.2006-2843
   PubMed Web of Science ®Google Scholar
• Molatore S, Marinoni I, Lee M, Pulz E, Ambrosio MR, degli Uberti EC, Zatelli MC, Pellegata NS. A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization. Hum mutat 2010; 31:E1825-35; PMID:20824794; http://dx.doi.org/10.1002/humu.21354
   PubMed Web of Science ®Google Scholar
• Occhi G, Regazzo D, Trivellin G, Boaretto F, Ciato D, Bobisse S, Ferasin S, Cetani F, Pardi E, Korbonits M, et al. A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype. PLoS Genet 2013; 9:e1003350; PMID:23555276; http://dx.doi.org/10.1371/journal.pgen.1003350
   PubMed Web of Science ®Google Scholar
• Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 2008; 8:253-67; PMID:18354415; http://dx.doi.org/10.1038/nrc2347
   PubMed Web of Science ®Google Scholar
• Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000; 183:10-7; PMID:10699961; http://dx.doi.org/10.1002/(SICI)1097-4652(200004)183:1%3c10::AID-JCP2%3e3.0.CO;2-I
   PubMed Web of Science ®Google Scholar
• Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012; 486:353-60; PMID:22722193
   PubMed Web of Science ®Google Scholar
• Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012; 486:400-4; PMID:22722201
   PubMed Web of Science ®Google Scholar
• Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van Allen E, Stransky N, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 2012; 44:685-9; PMID:22610119; http://dx.doi.org/10.1038/ng.2279
   PubMed Web of Science ®Google Scholar
• Dietrich S, Hullein J, Lee SC, Hutter B, Gonzalez D, Jayne S, Dyer MJ, Oles M, Else M, Liu X, et al. Recurrent CDKN1B (p27) mutations in hairy cell leukemia. Blood 2015; 126:1005-8; PMID:26065650; http://dx.doi.org/10.1182/blood-2015-04-643361
   PubMed Web of Science ®Google Scholar
• Ponce-Castaneda MV, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J, et al. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer research 1995; 55:1211-4; PMID:7882310
   PubMed Web of Science ®Google Scholar
• Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S, et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 1995; 55:2266-9; PMID:7757974
   PubMed Web of Science ®Google Scholar
• Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP. p27/Kip1 mutation found in breast cancer. Cancer Res 1996; 56:2400-4; PMID:8625318
   PubMed Web of Science ®Google Scholar
• Tanaka C, Yoshimoto K, Yang P, Kimura T, Yamada S, Moritani M, Sano T, Itakura M. Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas. The Journal of clinical endocrinology and metabolism 1997; 82:3141-7; PMID:9284759
   PubMed Web of Science ®Google Scholar
• Chen G, Cheng Y, Zhang Z, Martinka M, Li G. Prognostic significance of cytoplasmic p27 expression in human melanoma. Cancer epidemiol biomarkers Prev 2011; 20:2212-21; PMID:21828232; http://dx.doi.org/10.1158/1055-9965.EPI-11-0472
   PubMed Web of Science ®Google Scholar
• Denicourt C, Saenz CC, Datnow B, Cui XS, Dowdy SF. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res 2007; 67:9238-43; PMID:17909030; http://dx.doi.org/10.1158/0008-5472.CAN-07-1375
   PubMed Web of Science ®Google Scholar
• Rosen DG, Yang G, Cai KQ, Bast RC, Jr., Gershenson DM, Silva EG, Liu J. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer. Clin Cancer Res 2005; 11:632-7; PMID:15701850
   PubMed Web of Science ®Google Scholar
• Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002; 8:1153-60; PMID:12244302; http://dx.doi.org/10.1038/nm761
   PubMed Web of Science ®Google Scholar
• Singh SP, Lipman J, Goldman H, Ellis FH, Jr., Aizenman L, Cangi MG, Signoretti S, Chiaur DS, Pagano M, Loda M. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res 1998; 58:1730-5; PMID:9563491
   PubMed Web of Science ®Google Scholar
• Kruck S, Merseburger AS, Hennenlotter J, Scharpf M, Eyrich C, Amend B, Sievert KD, Stenzl A, Bedke J. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma. BJU Int 2012; 109:1565-70; PMID:21981759; http://dx.doi.org/10.1111/j.1464-410X.2011.10649.x
   PubMed Web of Science ®Google Scholar
• Wander SA, Zhao D, Slingerland JM. p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin Cancer Res 2011; 17:12-8; PMID:20966355; http://dx.doi.org/10.1158/1078-0432.CCR-10-0752
   PubMed Web of Science ®Google Scholar
• Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: integrating signals from front to back. Science 2003; 302:1704-9; PMID:14657486; http://dx.doi.org/10.1126/science.1092053
   PubMed Web of Science ®Google Scholar
• Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002; 420:629-35; PMID:12478284; http://dx.doi.org/10.1038/nature01148
   PubMed Web of Science ®Google Scholar
• Butty AC, Pryciak PM, Huang LS, Herskowitz I, Peter M. The role of Far1p in linking the heterotrimeric G protein to polarity establishment proteins during yeast mating. Science 1998; 282:1511-6; PMID:9822386; http://dx.doi.org/10.1126/science.282.5393.1511
   PubMed Web of Science ®Google Scholar
• Shimada Y, Gulli MP, Peter M. Nuclear sequestration of the exchange factor Cdc24 by Far1 regulates cell polarity during yeast mating. Nat Cell Biol 2000; 2:117-24; PMID:10655592; http://dx.doi.org/10.1038/35000073
   PubMed Web of Science ®Google Scholar
• McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 2003; 23:216-28; PMID:12482975; http://dx.doi.org/10.1128/MCB.23.1.216-228.2003
   PubMed Web of Science ®Google Scholar
• Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 1998; 4:1449-52; PMID:9846587; http://dx.doi.org/10.1038/4042
   PubMed Web of Science ®Google Scholar
• Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18:862-76; PMID:15078817; http://dx.doi.org/10.1101/gad.1185504
   PubMed Web of Science ®Google Scholar
• Wu FY, Wang SE, Sanders ME, Shin I, Rojo F, Baselga J, Arteaga CL. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Cancer Res 2006; 66:2162-72; PMID:16489017; http://dx.doi.org/10.1158/0008-5472.CAN-05-3304
   PubMed Web of Science ®Google Scholar
• Li Z, Jiao X, Wang C, Ju X, Lu Y, Yuan L, Lisanti MP, Katiyar S, Pestell RG. Cyclin D1 induction of cellular migration requires p27(KIP1). Cancer Res 2006; 66:9986-94; PMID:17047061; http://dx.doi.org/10.1158/0008-5472.CAN-06-1596
   PubMed Web of Science ®Google Scholar
• Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci U S A 2009; 106:9268-73; PMID:19470470; http://dx.doi.org/10.1073/pnas.0805057106
   PubMed Web of Science ®Google Scholar
• Kawauchi T, Chihama K, Nabeshima Y, Hoshino M. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 2006; 8:17-26; PMID:16341208; http://dx.doi.org/10.1038/ncb1338
   PubMed Web of Science ®Google Scholar
• Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, Roberts JM, Guillemot F. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 2006; 20:1511-24; PMID:16705040; http://dx.doi.org/10.1101/gad.377106
   PubMed Web of Science ®Google Scholar
• Godin JD, Thomas N, Laguesse S, Malinouskaya L, Close P, Malaise O, Purnelle A, Raineteau O, Campbell K, Fero M, et al. p27(Kip1) is a microtubule-associated protein that promotes microtubule polymerization during neuron migration. Dev Cell 2012; 23:729-44; PMID:23022035; http://dx.doi.org/10.1016/j.devcel.2012.08.006
   PubMed Web of Science ®Google Scholar
• Goukassian D, Diez-Juan A, Asahara T, Schratzberger P, Silver M, Murayama T, Isner JM, Andres V. Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. FASEB J 2001; 15:1877-85; PMID:11532967; http://dx.doi.org/10.1096/fj.01-0065com
   PubMed Web of Science ®Google Scholar
• Sun J, Marx SO, Chen HJ, Poon M, Marks AR, Rabbani LE. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. Circulation 2001; 103:2967-72; PMID:11413088; http://dx.doi.org/10.1161/01.CIR.103.24.2967
   PubMed Web of Science ®Google Scholar
• Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V, Colombatti A. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 2005; 7:51-63; PMID:15652749; http://dx.doi.org/10.1016/j.ccr.2004.11.025
   PubMed Web of Science ®Google Scholar
• Schiappacassi M, Lovat F, Canzonieri V, Belletti B, Berton S, Di Stefano D, Vecchione A, Colombatti A, Baldassarre G. p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. Mol Cancer ther 2008; 7:1164-75; PMID:18483304; http://dx.doi.org/10.1158/1535-7163.MCT-07-2154
   PubMed Web of Science ®Google Scholar
• Belletti B, Pellizzari I, Berton S, Fabris L, Wolf K, Lovat F, Schiappacassi M, D'Andrea S, Nicoloso MS, Lovisa S, et al. p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. Mol Cell Biol 2010; 30:2229-40; PMID:20194624; http://dx.doi.org/10.1128/MCB.00723-09
   PubMed Web of Science ®Google Scholar
• Berton S, Belletti B, Wolf K, Canzonieri V, Lovat F, Vecchione A, Colombatti A, Friedl P, Baldassarre G. The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition. Mol Cell Biol 2009; 29:5031-45; PMID:19596789; http://dx.doi.org/10.1128/MCB.00144-09
   PubMed Web of Science ®Google Scholar
• Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, Sun P, Tan CK, Hengst L, Slingerland J. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 2007; 128:281-94; PMID:17254967; http://dx.doi.org/10.1016/j.cell.2006.11.049
   PubMed Web of Science ®Google Scholar
• Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel EM, Waddell MB, Jakel H, Kullmann M, Kriwacki RW, Hengst L. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 2007; 128:269-80; PMID:17254966; http://dx.doi.org/10.1016/j.cell.2006.11.047
   PubMed Web of Science ®Google Scholar
• Cheli Y, Giuliano S, Botton T, Rocchi S, Hofman V, Hofman P, Bahadoran P, Bertolotto C, Ballotti R. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene 2011; 30:2307-18; PMID:21278797; http://dx.doi.org/10.1038/onc.2010.598
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011; 331:1559-64; PMID:21436443; http://dx.doi.org/10.1126/science.1203543
   PubMed Web of Science ®Google Scholar
• Besson A, Hwang HC, Cicero S, Donovan SL, Gurian-West M, Johnson D, Clurman BE, Dyer MA, Roberts JM. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 2007; 21:1731-46; PMID:17626791; http://dx.doi.org/10.1101/gad.1556607
   PubMed Web of Science ®Google Scholar
• Serres MP, Zlotek-Zlotkiewicz E, Concha C, Gurian-West M, Daburon V, Roberts JM, Besson A. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro. Oncogene 2011; 30:2846-58; PMID:21317921; http://dx.doi.org/10.1038/onc.2011.9
   PubMed Web of Science ®Google Scholar
• Menchon C, Edel MJ, Izpisua Belmonte JC. The cell cycle inhibitor p27(Kip)(1) controls self-renewal and pluripotency of human embryonic stem cells by regulating the cell cycle, Brachyury and Twist. Cell Cycle 2011; 10:1435-47; PMID:21478681; http://dx.doi.org/10.4161/cc.10.9.15421
   PubMed Web of Science ®Google Scholar
• Egozi D, Shapira M, Paor G, Ben-Izhak O, Skorecki K, Hershko DD. Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells. FASEB J 2007; 21:2807-17; PMID:17475922; http://dx.doi.org/10.1096/fj.06-7758com
   PubMed Web of Science ®Google Scholar
• Bryja V, Cajanek L, Pachernik J, Hall AC, Horvath V, Dvorak P, Hampl A. Abnormal development of mouse embryoid bodies lacking p27Kip1 cell cycle regulator. Stem Cells 2005; 23:965-74; PMID:15941856; http://dx.doi.org/10.1634/stemcells.2004-0174
   PubMed Web of Science ®Google Scholar
• Li H, Collado M, Villasante A, Matheu A, Lynch CJ, Canamero M, Rizzoti K, Carneiro C, Martinez G, Vidal A, et al. p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation. Cell Stem Cell 2012; 11:845-52; PMID:23217425; http://dx.doi.org/10.1016/j.stem.2012.09.014
   PubMed Web of Science ®Google Scholar
• Pippa R, Espinosa L, Gundem G, Garcia-Escudero R, Dominguez A, Orlando S, Gallastegui E, Saiz C, Besson A, Pujol MJ, et al. p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes. Oncogene 2012; 31:4207-20; PMID:22179826; http://dx.doi.org/10.1038/onc.2011.582
   PubMed Web of Science ®Google Scholar
• Zhao D, Besser AH, Wander SA, Sun J, Zhou W, Wang B, Ince T, Durante MA, Guo W, Mills G, et al. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation. Oncogene 2015; 34:5447-59; PMID:25684140; http://dx.doi.org/10.1038/onc.2014.473
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-54; PMID:12189386; http://dx.doi.org/10.1038/nrc822
   PubMed Web of Science ®Google Scholar
• Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704-15; PMID:18485877; http://dx.doi.org/10.1016/j.cell.2008.03.027
   PubMed Web of Science ®Google Scholar
• Sharma SS, Ma L, Bagui TK, Forinash KD, Pledger WJ. A p27(Kip1) mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation. Oncogene 2011; PMID:22158041
   PubMed Web of Science ®Google Scholar
• Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 1997; 16:5334-44; PMID:9311993; http://dx.doi.org/10.1093/emboj/16.17.5334
   PubMed Web of Science ®Google Scholar
• Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R, Tsukiyama T, Ishida N, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 2000; 19:2069-81; PMID:10790373; http://dx.doi.org/10.1093/emboj/19.9.2069
   PubMed Web of Science ®Google Scholar
• Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S, Kitagawa M, Iemura S, Natsume T, Nakayama KI. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 2004; 6:661-72; PMID:15130491; http://dx.doi.org/10.1016/S1534-5807(04)00131-5
   PubMed Web of Science ®Google Scholar
• Payne SR, Zhang S, Tsuchiya K, Moser R, Gurley KE, Longton G, deBoer J, Kemp CJ. p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability. Mol Cell Biol 2008; 28:258-68; PMID:17954563; http://dx.doi.org/10.1128/MCB.01536-07
   PubMed Web of Science ®Google Scholar
• Moeller SJ, Head ED, Sheaff RJ. p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation. Mol Cell Biol 2003; 23:3735-52; PMID:12748278; http://dx.doi.org/10.1128/MCB.23.11.3735-3752.2003
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Tomoda K, Tanaka T, Arata Y, Yoneda-Kato N, Kato J. Direct binding of the signal-transducing adaptor Grb2 facilitates down-regulation of the cyclin-dependent kinase inhibitor p27Kip1. J Biol Chem 2001; 276:12084-90; PMID:11278754; http://dx.doi.org/10.1074/jbc.M010811200
   PubMed Web of Science ®Google Scholar
• Fabris L, Berton S, Pellizzari I, Segatto I, D'Andrea S, Armenia J, Bomben R, Schiappacassi M, Gattei V, Philips MR, et al. p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability. Proc Natl Acad Sci U S A 2015; 112:13916-21; PMID:26512117; http://dx.doi.org/10.1073/pnas.1508514112
   PubMed Web of Science ®Google Scholar
• Berton S, Pellizzari I, Fabris L, D'Andrea S, Segatto I, Canzonieri V, Marconi D, Schiappacassi M, Benevol S, Gattei V, et al. Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo. Cell Cycle 2014; 13:3100-11; PMID:25486569; http://dx.doi.org/10.4161/15384101.2014.949512
   PubMed Web of Science ®Google Scholar
• Jeannot P, Callot C, Baer R, Duquesnes N, Guerra C, Guillermet-Guibert J, Bachs O, Besson A. Loss of p27Kip1 promotes metaplasia in the pancreas via the regulation of Sox9 expression. Oncotarget 2015; 6:35880-92; PMID:26416424
   PubMed Web of Science ®Google Scholar
• Perez-Luna M, Aguasca M, Perearnau A, Serratosa J, Martinez-Balbas M, Jesus Pujol M, Bachs O. PCAF regulates the stability of the transcriptional regulator and cyclin-dependent kinase inhibitor p27 Kip1. Nucleic Acids Res 2012; 40:6520-33; PMID:22547391; http://dx.doi.org/10.1093/nar/gks343
   PubMed Web of Science ®Google Scholar
• Armenia J, Fabris L, Lovat F, Berton S, Segatto I, D'Andrea S, Ivan C, Cascione L, Calin GA, Croce CM, et al. Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner. Oncotarget 2014; 5:1185-97; PMID:24727437; http://dx.doi.org/10.18632/oncotarget.1803
   PubMed Web of Science ®Google Scholar
• Nallamshetty S, Crook M, Boehm M, Yoshimoto T, Olive M, Nabel EG. The cell cycle regulator p27Kip1 interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication. FEBS letters 2005; 579:6529-36; PMID:16289477; http://dx.doi.org/10.1016/j.febslet.2005.10.028
   PubMed Web of Science ®Google Scholar
• Sharma SS, Ma L, Pledger WJ. p27Kip1 inhibits the cell cycle through non-canonical G1/S phase-specific gatekeeper mechanism. Cell Cycle 2015; 14:3954-64; PMID:26697844; http://dx.doi.org/10.1080/15384101.2015.1100775
   PubMed Web of Science ®Google Scholar
• Tetzlaff MT, Bai C, Finegold M, Wilson J, Harper JW, Mahon KA, Elledge SJ. Cyclin F disruption compromises placental development and affects normal cell cycle execution. Mol Cell Biol 2004; 24:2487-98; PMID:14993286; http://dx.doi.org/10.1128/MCB.24.6.2487-2498.2004
   PubMed Web of Science ®Google Scholar
• D'Angiolella V, Donato V, Vijayakumar S, Saraf A, Florens L, Washburn MP, Dynlacht B, Pagano M. SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation. Nature 2010; 466:138-42; PMID:20596027; http://dx.doi.org/10.1038/nature09140
   PubMed Web of Science ®Google Scholar
• Bai C, Richman R, Elledge SJ. Human cyclin F. EMBO J 1994; 13:6087-98; PMID:7813445
   PubMed Web of Science ®Google Scholar
• Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW, Elledge SJ. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 1996; 86:263-74; PMID:8706131; http://dx.doi.org/10.1016/S0092-8674(00)80098-7
   PubMed Web of Science ®Google Scholar
• Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2002; 2:815-25; PMID:12415252; http://dx.doi.org/10.1038/nrc924
   PubMed Web of Science ®Google Scholar
• Kazi A, Carie A, Blaskovich MA, Bucher C, Thai V, Moulder S, Peng H, Carrico D, Pusateri E, Pledger WJ, et al. Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy. Mol Cell Biol 2009; 29:2254-63; PMID:19204084; http://dx.doi.org/10.1128/MCB.01029-08
   PubMed Web of Science ®Google Scholar
• Chen Q, Xie W, Kuhn DJ, Voorhees PM, Lopez-Girona A, Mendy D, Corral LG, Krenitsky VP, Xu W, Moutouh-de Parseval L, et al. Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy. Blood 2008; 111:4690-9; PMID:18305219; http://dx.doi.org/10.1182/blood-2007-09-112904
   PubMed Web of Science ®Google Scholar
• Chan CH, Morrow JK, Li CF, Gao Y, Jin G, Moten A, Stagg LJ, Ladbury JE, Cai Z, Xu D, et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 2013; 154:556-68; PMID:23911321; http://dx.doi.org/10.1016/j.cell.2013.06.048
   PubMed Web of Science ®Google Scholar
• Lovisa S, Citro S, Sonego M, Dall'Acqua A, Ranzuglia V, Berton S, Colombatti A, Belletti B, Chiocca S, Schiappacassi M, et al. SUMOylation regulates p27Kip1 stability and localization in response to TGFbeta. J Mol Cell Biol 2015; PMID:26450989
   PubMed Web of Science ®Google Scholar
• Connor MK, Kotchetkov R, Cariou S, Resch A, Lupetti R, Beniston RG, Melchior F, Hengst L, Slingerland JM. CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. Mol Biol Cell 2003; 14:201-13; PMID:12529437; http://dx.doi.org/10.1091/mbc.E02-06-0319
   PubMed Web of Science ®Google Scholar
• Smitherman M, Lee K, Swanger J, Kapur R, Clurman BE. Characterization and targeted disruption of murine Nup50, a p27(Kip1)-interacting component of the nuclear pore complex. Mol Cell Biol 2000; 20:5631-42; PMID:10891500; http://dx.doi.org/10.1128/MCB.20.15.5631-5642.2000
   PubMed Web of Science ®Google Scholar
• Muller D, Thieke K, Burgin A, Dickmanns A, Eilers M. Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60. EMBO J 2000; 19:2168-80; PMID:10811608; http://dx.doi.org/10.1093/emboj/19.10.2168
   PubMed Web of Science ®Google Scholar